In this issue:
Brexpiprazole in adolescent schizophrenia
Sedative AEs with antipsychotics
Machine learning to predict schizophrenia
Blood leukocyte subpopulations in schizophrenia
Multimodal structural brain variability in schizophrenia
Mortality risks with antipsychotics
Increased risk of breast cancer in schizophrenia
Genetic liability for treatment-resistant schizophrenia & distinct dopamine synthesis capacity
Real-world, long-term efficacy of aripiprazole LAI
Schizophrenia rates with mandatory folic acid fortification
Please login below to download this issue (PDF)